Effect of FTY720 Treatment on Postischemic Pancreatic Microhemodynamics

被引:4
|
作者
Prescher, A. [1 ]
Mory, C. [1 ]
Martin, M. [1 ]
Fiedler, M. [2 ]
Uhlmann, D. [1 ]
机构
[1] Univ Leipzig, Dept Surg 2, D-04103 Leipzig, Germany
[2] Univ Leipzig, Dept Lab Med, D-04103 Leipzig, Germany
关键词
IMMUNOSUPPRESSANT; TRANSPLANTATION; LYMPHOCYTES; INJURY; LIVER; RATS;
D O I
10.1016/j.transproceed.2010.09.046
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4+ T cells contribute to disturbances of pancreatic microcirculation after cold and even after warm ischemia/reperfusion (I/R). The aim of this study was to inyestigate a possible protective role of FTY720 (fingolimod) in this setting. In an in vivo model (42 Wistar rats), ischemia of the pancreas was induced for 60 minutes under anesthesia with xylazin/ ketanest. Sham-operated (SO) (I), untreated ischemic (II), and treatment group with FTY720 pre-treatment (1 mg/kg body weight IV) (III) were investigated. The effect of FTY720 on I/R injury was assessed by in vivo microscopy 30-90 minutes after reperfusion and by measurement of serum lipase. In the untreated ischemic group (II), capillary constriction to 85.3 +/- 6.3% of SO diameters and a reduction of functional capillary density to 67% was found. After 30 minutes of reperfusion, the number of T cells in capillaries was increased (165.7%; P <.05 vs I). FTY720 pretreatment reduced this number to 54.2% of SO (P <.05 vs II). Likewise, the number of adherent leukocytes in capillaries (145.4 +/- 11.2% of SO) was reduced in group III (109.3 +/- 11.4%; P <.05 vs II), leading to an improvement in functional capillary density in the treatment group (98.2 +/- 2% of SO; P <.05 vs II). According to improved microcirculation, lipase values were reduced in the therapy group (P <.05). In conclusion, FTY720 ameliorates the microcirculatory and biochemical manifestations of pancreatic I/R injury by preventing T-cell infiltration.
引用
收藏
页码:3984 / 3985
页数:2
相关论文
共 50 条
  • [1] The FTY720 story
    Napoli, KL
    THERAPEUTIC DRUG MONITORING, 2000, 22 (01) : 47 - 51
  • [2] The Effect of FTY720 in an Animal Model of MS
    Pachner, Andrew R.
    Apte, Priyanka
    Brady, Jennifer
    Li, Libin
    ANNALS OF NEUROLOGY, 2009, 66 : S33 - S34
  • [3] Perspective on FTY720, an Immunosuppressant
    Balasubramaniam, Sivaraman
    Sankaran, Ganapathy Subramanian
    Badle, Sneh Sanjay
    SYNTHESIS-STUTTGART, 2018, 50 (05): : 968 - 983
  • [4] FTY720 for cancer therapy
    Zhang, Li
    Wang, Han-Dong
    Ji, Xiang-Jun
    Cong, Zi-Xiang
    Zhu, Jian-Hong
    Zhou, Yuan
    ONCOLOGY REPORTS, 2013, 30 (06) : 2571 - 2578
  • [5] Prolongation of concordant xenograft survival by treatment with FTY720
    Miyata, Y
    Ohdan, H
    Noriyuki, T
    Shintaku, S
    Shibata, S
    Yamamoto, H
    Fan, XH
    Fudaba, Y
    Yoshioka, S
    Asahara, T
    Fukuda, Y
    Dohi, K
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4163 - 4165
  • [6] FTY720 (fingolimod) treatment suppresses autoimmune uveoretinitis
    Copland, D.
    Brinkmann, V.
    Nuesslein-Hildesheim, B.
    Anderson, K.
    Brigell, M.
    Liu, J.
    Nicholson, L.
    Dick, A.
    IMMUNOLOGY, 2010, 131 : 83 - 83
  • [7] Current perspectives on FTY720
    Martini, Sebastian
    Peters, Harm
    Boehler, Torsten
    Budde, Klemens
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (04) : 505 - 518
  • [8] Preparation of antibodies against a novel immunosuppressant, FTY720, and development of an enzyme immunoassay for FTY720
    Matsumoto, Norimasa
    Kohno, Takeyuki
    Uchida, Shuji
    Shimizu, Takaaki
    Kusumoto, Haruko
    Hirose, Ryoji
    Yanada, Kazuo
    Kurio, Wasako
    Yamaguchi, Shoji
    Watabe, Kazuhito
    Fujita, Tetsuro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (12) : 4182 - 4192
  • [9] The emerging role of FTY720 (Fingolimod) in cancer treatment
    White, Christopher
    Alshaker, Heba
    Cooper, Colin
    Winkler, Matthias
    Pchejetski, Dmitri
    ONCOTARGET, 2016, 7 (17) : 23106 - 23127
  • [10] Enantioselective Desymmetrization of FTY720
    Hikawa, Hidemasa
    Hamada, Maiko
    Uchida, Yuka
    Kikkawa, Shoko
    Yokoyama, Yuusaku
    Azumaya, Isao
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2014, 62 (10) : 1041 - 1044